Published in Schweiz Med Wochenschr on October 04, 1980
Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation (1981) 2.31
Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer (1993) 2.15
Tattoo removal by non-professionals--medical and forensic considerations. J Eur Acad Dermatol Venereol (2009) 2.07
Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92
Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting. Anesth Analg (2001) 1.78
Sexuality among gynecologic cancer patients--a cross-sectional study. Gynecol Oncol (1994) 1.66
High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol (1990) 1.54
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood (1995) 1.52
Finite difference solution for biopotentials of axially symmetric cells. Biophys J (1972) 1.47
Combined high-dose 7S-IgG and dexamethasone is effective in severe polyneuropathy of the POEMS syndrome. J Neurol (1995) 1.39
Climate change. Preparing for resettlement associated with climate change. Science (2011) 1.32
A high-throughput screening for mammalian cell death effectors identifies the mitochondrial phosphate carrier as a regulator of cytochrome c release. Oncogene (2007) 1.25
Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol (1979) 1.23
Sinus histiocytosis with massive lymphadenopathy: evidence for its relationship to macrophages and for a cytokine-related disorder. Histopathology (1999) 1.20
[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13
Stimulation of spheroidal cells--the role of cell shape. IEEE Trans Biomed Eng (1976) 1.11
Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11
Crystal structure of bovine beta-trypsin at 1.5 A resolution in a crystal form with low molecular packing density. Active site geometry, ion pairs and solvent structure. J Mol Biol (1989) 1.08
Computed potentials of cortically arranged populations of neurons. J Neurophysiol (1977) 1.06
Cognitive dysfunction and subjective complaints of cancer patients. a cross-sectional study in a cancer rehabilitation centre. Eur J Cancer (2004) 1.04
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01
Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood (1992) 1.00
Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results. Psychooncology (2009) 1.00
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97
Blood coagulation studies in domestic pigs (Hanover breed) and minipigs (Goettingen breed). Lab Anim (1983) 0.94
Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94
Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94
Overwhelming infection after splenectomy in spite of some spleen remaining and splenosis. A case report. Klin Wochenschr (1983) 0.92
Factor XII (Hageman) deficiency in women with habitual abortion: new subpopulation of recurrent aborters? Fertil Steril (1993) 0.92
Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91
Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med (2013) 0.89
Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89
Complement system in sodium taurocholate pancreatitis in the rat. Res Exp Med (Berl) (1978) 0.88
Accuracy and precision in protein crystal structure analysis: two independent refinements of the structure of poplar plastocyanin at 173 K. Acta Crystallogr D Biol Crystallogr (1994) 0.87
[Peritoneal dialysis and local thrombolysis in hemophilia A with postrenal kidney failure]. Z Urol Nephrol (1972) 0.87
Solid-phase radioimmunoassay for detection of alcoholic hyalin antigen (AHAg) and antibody (anti-AH). Clin Exp Immunol (1981) 0.87
Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.87
Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy. J Psychosoc Oncol (2009) 0.86
Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86
Serum complement factors in human acute pancreatitis. Hepatogastroenterology (1981) 0.86
Cytokine production in leukocyte cultures during therapy with Echinacea extract. J Clin Lab Anal (1996) 0.86
Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86
Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenström's macroglobulinemia. Nephron (2000) 0.86
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: preliminary data of a phase-II study. Onkologie (1988) 0.85
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer (1984) 0.85
[Serological subtypes of hepatitis-B antigen (Australia antigen). Local hepatitis-B epidemic of the subtype "Y" with regionally predominating subtype "D"]. Dtsch Med Wochenschr (1972) 0.84
Immunological aspects of alcoholic hepatitis. Gastroenterology (1978) 0.84
Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL). J Cancer Res Clin Oncol (1979) 0.84
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol (1986) 0.84
[Lymphogranulomatosis and pregnancy]. Arch Klin Med (1967) 0.84
The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol (1970) 0.84
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding study. Onkologie (1988) 0.84
Intracellular biopotentials during static extracellular stimulation. Biophys J (1973) 0.83
Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res (1970) 0.83
Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83
Advantages of isovolemic large-volume erythrocytapheresis as a rapidly effective and long-lasting treatment modality for red blood cell depletion in patients with polycythemia vera. Ther Apher (1997) 0.82
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82
A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics. Am J Psychiatry (1969) 0.82
Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer Society. Onkologie (1990) 0.82
The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol (1982) 0.82
Identification of lymphocyte subpopulations by simultaneous E-rosette formation and unspecific acid esterase staining. Experientia (1978) 0.82
Tumor-associated antigens in effusions of malignant and benign origin. Clin Investig (1993) 0.81
IFN-gamma receptors on human tumor cells: relationship between receptor ligand interactions and induction of IFN-gamma response. Immunobiology (1986) 0.81
Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81
[Immunosuppression: a paraneoplastic syndrome]. Schweiz Med Wochenschr (1971) 0.81
[Intracoronary application of streptokinase in acute myocardial infarction and non-stable angina pectoris (author's transl)]. Dtsch Med Wochenschr (1980) 0.81
Liver histology in healthy carriers of Australia-SH antigen or antibodies. Ger Med Mon (1971) 0.81
[Intraoperative changes in extravascular lung water. Study on heart surgery patients]. Anaesthesist (1985) 0.81
[Angioimmunoblastic lymphadenopathy and persistent virus infection? Discussion of immunohistological findings on two cases (author's trsnsl)]. Klin Wochenschr (1979) 0.80
Palliative irradiation of bone metastases. Cancer Treat Rev (1989) 0.80
[Histological liver studies in healthy Australia(SH)-antigen and antibody carriers]. Dtsch Med Wochenschr (1970) 0.80
Mitomycin-induced haemolysis and renal failure. Lancet (1980) 0.80
Ovarian carcinoma: care and survival in a community-based population. Clin Ther (2001) 0.80
Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncol (1991) 0.80
[Influence of ovulation inhibitors on clinicochemical norms]. Dtsch Med Wochenschr (1969) 0.80
[Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr (1985) 0.80
Suppressed colony formation of peripheral blood lymphocytes in a patient with somatostatinoma. Clin Immunol Immunopathol (1986) 0.80
Continuous intravenous infusion of elastase in normal and agranulocytic minipigs--effects on the lungs and the blood coagulation system. Resuscitation (1986) 0.80
Sequence analysis of amplified t(14;18) chromosomal breakpoints in B-cell lymphomas. J Pathol (1990) 0.80
[Australia (SH) antigen findings in patients with liver diseases and blood donors]. Dtsch Med Wochenschr (1970) 0.80
Common errors in the treatment of suicidal patients. J Clin Psychiatry (1978) 0.80
Management of cancer pain in Denmark: a nationwide questionnaire survey. Pain (1996) 0.80
[Metastasizing adenocarcinoma from an unknown primary tumor]. Dtsch Med Wochenschr (1984) 0.79
Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res (1982) 0.79
Frequency and structure of t(14;18) major breakpoint regions in non-Hodgkin's lymphomas typed according to the Kiel classification: analysis by direct DNA sequencing. Cancer Res (1991) 0.79
Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J Clin Lab Immunol (1985) 0.79
[Reopening of infarct-occluded vessel by transluminal recanalisation and intracoronary streptokinase application (author's transl)]. Dtsch Med Wochenschr (1979) 0.79
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for metastatic gastric leiomyosarcoma. Bone Marrow Transplant (1997) 0.79
Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79
Aminoglutethimide. Penetration of the blood brain barrier. Invest New Drugs (1986) 0.79